Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) primarily replicates in
mucosal sites, and more information is needed about immune responses in infected tissues …

With a global tally of more than 500 million cases of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infections to date, there are growing concerns about the post …

Simple Summary Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
responsible for the pandemic coronavirus disease-2019 (COVID-19), which can lead to …

Rationale: Much is known about the acute infective process of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), the causative virus of the coronavirus disease …

The novel coronavirus SARS-CoV-2, etiological agent of recently named Coronavirus
infected disease (COVID-19) by WHO, has caused more than 2, 000 deaths worldwide since …

BACKGROUND Marked progress is achieved in understanding the physiopathology of
coronavirus disease 2019 (COVID-19), which caused a global pandemic. However, the …

The molecular properties of CD8+ T cells that respond to SARS-CoV-2 infection are not fully
known. Here, we report on the single-cell transcriptomes of> 80,000 virus-reactive CD8+ T …

Virus-specific humoral and cellular immunity act synergistically to protect the host from viral
infection. We interrogate the dynamic changes of virological and immunological parameters …

Herein we measured CD4+ T-cell responses against common cold coronaviruses (CCC)
and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in high-risk health care …

Cell-mediated immunity is critical for long-term protection against most viral infections,
including coronaviruses. We studied 23 severe acute respiratory syndrome coronavirus 2 …